| Members |
targetComponentId |
| Papillært serøst cystadenokarcinom |
Serous cystadenocarcinoma |
| Papillary serous cystadenoma, borderline malignancy |
Serous papillary cystic tumor of borderline malignancy |
| papillom (undtagen blærepapillom M-81201) |
Benign papilloma (morphologic abnormality) |
| para-aminophenolderivat antiinflammatorisk middel |
Para-aminophenol derivative |
| Paracetamol + chlorpheniramine maleate + phenylephrine hydrochloride 500mg/8mg/40mg |
Product containing only chlorphenamine and paracetamol and phenylephrine (medicinal product) |
| Paracetamol + orphenadrine citrate 500mg/50mg |
Orphenadrine and paracetamol only product |
| Paracetamol - chemical |
Product containing paracetamol (medicinal product) |
| Paracetamol 1g/sachet powder |
Paracetamol only product |
| Paracetamol 1g/sachet powder |
Paracetamol only product |
| paracetamol 500 mg opløselig tablet |
Product containing precisely paracetamol 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
| paracetamol + pentazocinhydrochlorid kapselformet 650 mg tablet |
Paracetamol 650 mg and pentazocine 25 mg oral tablet |
| Paracetamol 650mg / pentazocine hydrochloride 25mg conventional release oral tablet |
Paracetamol 650 mg and pentazocine 25 mg oral tablet |
| Paracetamol level abnormal |
Acetaminophen above therapeutic range |
| Paracetamol level normal |
Acetaminophen within therapeutic range |
| paracetamol 500 mg + caffein 65 mg opløselig tablet |
Product containing precisely caffeine 650 microgram/1 milliliter and paracetamol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Parafollicular cell carcinoma |
Medullary thyroid carcinoma |
| Parafunctional occlusal trauma |
Secondary occlusal trauma |
| Parahyaena brunnea |
Hyaena brunnea (organism) |
| Paramyxovirus |
Genus Respirovirus (organism) |
| Paramyxovirus group |
Genus Respirovirus (organism) |
| Paraplegia, brachydactyly, cone-shaped epiphysis syndrome |
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (disorder) |
| Parascapular fasciocutaneous flap |
Fasciocutaneous flap |
| Parascapular fasciocutaneous flap plus scapula |
Osteofasciocutaneous flap (substance) |
| Parasomnia disorder caused by substance |
Parasomnia |
| Parathormone |
Parathyroid hormone |
| Parathyroideahormonrelateret peptidsecernerende tumor |
Parathyroid hormone-related peptide-secreting tumor of pancreas (disorder) |
| Paratyfus-eksantem |
Eruption of skin caused by Salmonella Paratyphi |
| Parecoxib 40mg (injection pdr for recon) |
Parecoxib only product |
| parecoxib 40 mg injektion (pulver til rekonstitution) + diluent |
Parecoxib only product |
| Parecoxib 40mg injection (pdr for recon)+diluent |
Parecoxib only product |
| Parent craft class NOS |
Parent craft classes |
| Parent craft class NOS |
Parent craft classes |
| forælder er handicappet |
Parent has disability |
| patients forælder |
Parent |
| Parental reassurance |
Providing reassurance to parent |
| beroligelse af forælder |
Providing reassurance to parent |
| antikoagulans til parenteral anvendelse |
Anticoagulant (substance) |
| allergi over for glyceryltrinitrat til parenteral anvendelse |
Allergy to nitroglycerin |
| Parenteral intake process |
The act of putting or inserting an object AND/OR substance into or onto the body. |
| allergi over for isoprenalin til parenteral anvendelse |
Allergy to isoprenaline |
| allergi over for isosorbiddinitrat til parenteral anvendelse |
Allergy to isosorbide (finding) |
| allergi over for kalium til parenteral anvendelse |
Propensity to adverse reaction to potassium (finding) |
| Parents benefit NOS |
Parent's benefits |
| Parents benefit NOS |
Parent's benefits |
| Paritet, ikke nærmere specificeret |
Parity finding |
| Parity NOS |
Parity |
| Parkinson's disease NOS |
Parkinson's disease |
| Parkinsons sygdom, ikke nærmere specificeret |
Parkinson's disease |
| Parkinsondemenskompleks fra Guam |
A rare neurodegenerative disease characterized by extrapyramidal symptoms (rigidity, tremor, bradykinesia) and dementia, typically beginning in the fifth or sixth decade of life and progressing to a vegetative state with pelvicrural flexion contractures within few years. Oculomotor signs, olfactory dysfunction, and autonomic disturbances may also be observed. Neuropathological hallmarks are frontotemporally accentuated cerebral atrophy, as well as neurofibrillary tangles and neuronal loss in a characteristic distribution in cortical and subcortical regions. The disease is endemic to the Pacific Island of Guam. |
| Paromomycin |
Paromomycin |
| Paroophoron |
Wolffian body rest |
| røntgenundersøgelse af glandula parotidea |
Plain X-ray of parotid gland (procedure) |
| Paroxetine 12.5mg gastro-resistant and prolonged-release oral tablet |
Product containing only paroxetine in oral dose form (medicinal product form) |
| paroxetin 12,5 mg tablet med kontrolleret udløsning |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 25mg gastro-resistant and prolonged-release oral tablet |
Product containing only paroxetine in oral dose form (medicinal product form) |
| paroxetin 25 mg tablet med kontrolleret udløsning |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine 37.5mg gastro-resistant and prolonged-release oral tablet |
Product containing only paroxetine in oral dose form (medicinal product form) |
| paroxetin 37,5 mg tablet med kontrolleret udløsning |
Product containing only paroxetine in oral dose form (medicinal product form) |
| Paroxetine hydrochloride 10mg tablet |
Product containing precisely paroxetine (as paroxetine hydrochloride) 10 milligram/1 each conventional release oral tablet (clinical drug) |
| Paroxetine hydrochloride 20mg tablet |
Product containing precisely paroxetine (as paroxetine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) |
| Paroxetine hydrochloride 30mg tablet |
Paroxetine (as paroxetine hydrochloride) 30 mg oral tablet |
| Paroxetine hydrochloride 40mg tablet |
Paroxetine (as paroxetine hydrochloride) 40 mg oral tablet |
| Paroxetine mesylate 10mg tablet |
Product containing precisely paroxetine (as paroxetine mesilate) 10 milligram/1 each conventional release oral tablet (clinical drug) |
| Paroxetine mesylate 20mg tablet |
Product containing precisely paroxetine (as paroxetine mesilate) 20 milligram/1 each conventional release oral tablet (clinical drug) |
| Paroxetine mesylate 30mg tablet |
Paroxetine (as paroxetine mesilate) 30 mg oral tablet |
| Paroxetine mesylate 40mg tablet |
Paroxetine (as paroxetine mesilate) 40 mg oral tablet |
| Parsley - dietary |
Parsley (substance) |
| Parsley - dietary |
Parsley (substance) |
| Partial avulsion of nail |
Partial excision of nail and nail matrix |
| Partial avulsion of tooth |
Extrusive luxation of tooth |
| partiel deling af øjenmuskelsene, nærmere specificeret |
Partial division of tendon of muscle of eye |
| partiel epilepsi med autonome symptomer |
A type of epilepsy with only focal onset epileptic seizures. Seizures can arise from a single location or multiple locations. |
| partiel epilepsi med bevidsthedssvækkelse |
A type of epilepsy with only focal onset epileptic seizures. Seizures can arise from a single location or multiple locations. |
| partiel epilepsi med bevidsthedssvækkelse, ikke nærmere specificeret |
A type of epilepsy with only focal onset epileptic seizures. Seizures can arise from a single location or multiple locations. |
| Partial epileptic seizure of frontal lobe with impairment of consciousness |
An epileptic seizure originating within unilateral networks limited to the frontal lobe. The frontal lobe gives rise to seizures with distinctive features depending on the area of the frontal lobe involved. Motor features may be prominent. These seizures typically last 10 to 40 seconds and have minimal postictal confusion. |
| Partial epileptic seizure of occipital lobe with impairment of consciousness |
An epileptic seizure originating within unilateral networks limited to the occipital lobe. Seizures arising in the occipital lobe are characterised by subjective visual phenomenon and/or oculomotor features such as forced eye closure, eyelid fluttering, eye deviation and nystagmus. |
| Partial epileptic seizure of parietal lobe with impairment of consciousness |
An epileptic seizure originating within unilateral networks limited to the parietal lobe. Positive and/or negative sensory features occur. Typically, paresthesia is reported but disorientation, complex visual hallucinations, vertiginous and visual illusions and disturbance of body image (somatic illusion) can occur. Receptive language impairment can occur with dominant hemisphere involvement. Ipsilateral or contralateral rotatory body movements can occur. |
| Partial epileptic seizure of temporal lobe with impairment of consciousness |
An epileptic seizure originating within unilateral networks limited to the temporal lobe. Temporal lobe seizures are characterized by behavioral arrest and impaired awareness. There may be sensory (auditory), emotional (fear), cognitive (deja vu) or autonomic features (epigastric sensation, tachycardia, color change) in isolation or prior to onset of impaired awareness. Postictal confusion typically occurs. |
| Partiel excision |
Removal done with a cutting instrument |
| Partial excision of bladder NOS |
Partial cystectomy |
| Partiel excision af blæren, ikke nærmere specificeret |
Partial cystectomy |
| Partial excision of femur |
Partial ostectomy of femur |
| Partial excision of organ NOC |
Removal done with a cutting instrument |
| Partial excision of pituitary gland by unspecified approach |
Partial hypophysectomy |
| Partiel excision af mavesæk, ikke nærmere specificeret |
Subtotal gastrectomy |
| Partial excision of stomach NOS |
Subtotal gastrectomy |
| Partial frontal lobe epilepsy |
A type of focal epilepsy where all the seizures originate within the frontal lobe. |
| Partial hysterectomy |
Subtotal abdominal hysterectomy |
| Partial hysterectomy |
Subtotal abdominal hysterectomy |
| Partial occipital lobe epilepsy |
Occipital lobe epilepsy |
| Partial parietal lobe epilepsy |
A type of focal epilepsy where all the seizures originate within the parietal lobe. |
| Partiel ny nethindeløsning med multiple defekter |
Partial detachment of retina with multiple breaks of retina (disorder) |
| Partiel ny nethindeløsning med enkelt defekt |
Partial detachment of retina with single break of retina (disorder) |
| Partial replacement of joint of bilateral shoulder regions |
Partial replacement of joint of bilateral shoulders with prosthesis (procedure) |
| Partial salpingectomy: [NOS] or [NEC] |
Partial salpingectomy |
| Partielt anfald med illusioner og hallucinationer |
An epileptic seizure originating within networks limited to one hemisphere where disturbance of cognition is the predominant feature, regardless of whether aware or with impaired awareness. Cognitive deficits are deficits in language, thinking or associated higher cortical functions during seizures. |
| Partial thickness skin graft |
A graft of the epidermis and less than the entire thickness of the dermis of the skin. |
| Partner had vasectomy |
Partner had vasectomy (situation) |
| partner har fået foretaget vasektomi |
Partner had vasectomy (situation) |
| partner i parforhold med patient |
Partner in relationship |
| Parturient paresis |
Muscle weakness |
FHIR